По мнению большинства авторов СОVID-19 у детей протекает легче и зачастую
бессимптомно (от 1/5 до 1/3 случаев). В настоящее время сбор дополнительных
высококачественных сведений о течении и лечении COVID-19 у детей важен для выделения
наиболее эффективных алгоритмов ведения пациентов. Важное значение имеет надлежащий
мониторинг, раннее выявление осложнений заболевания, а также возможность своевременного
лечения и ограничения вторичного распространения инфекции.
По мнению большинства авторов СОVID-19 у детей протекает легче и зачастую
бессимптомно (от 1/5 до 1/3 случаев). В настоящее время сбор дополнительных
высококачественных сведений о течении и лечении COVID-19 у детей важен для выделения
наиболее эффективных алгоритмов ведения пациентов. Важное значение имеет надлежащий
мониторинг, раннее выявление осложнений заболевания, а также возможность своевременного
лечения и ограничения вторичного распространения инфекции.
Кўплаб муаллифлар фикрича, СОVID-19 болаларда анча енгил ва белгиларсиз кечади
(1/5 дан 1/3 гача ҳолатларда). Ҳозирги вақтга келиб, болаларда COVID-19 нинг кечиши ва
даволаниши тўғрисида қўшимча юқори сифатли маълумотларни тўплаш беморларни кузатиш
бўйича энг самарали алгоритмларни ажратиб кўрсатиш учун муҳимдир. Тўғри кузатув,
касалликнинг асоратларини эрта аниқлаш, шунингдек, ўз вақтида даволаш ва инфекциянинг
иккиламчи тарқалишини чеклаш имконияти муҳимдир.
Аccording to most authors, COVID-19 in children is easier and often asymptomatic (from 1/5
to 1/3 of cases). Currently, the collection of additional high-quality data on the course and treatment of
COVID-19 in children is important to highlight the most effective patient management algorithms.
Proper monitoring, early detection of complications of the disease, as well as the possibility of timely
treatment and limiting the secondary spread of infection are important.
| № | Author name | position | Name of organisation |
|---|---|---|---|
| 1 | Muxsinova M.X. | . | Ташкентский педиатрический медицинский институт |
| 2 | Axmedova D.I. | . | Ташкентский педиатрический медицинский институт |
| 3 | Abdurazakova Z.K. | . | Ташкентский педиатрический медицинский институт |
| 4 | Ortikov U.U. | . | Ташкентский педиатрический медицинский институт |
| № | Name of reference |
|---|---|
| 1 | 1. Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76– 77. doi:10.1016/s0140-6736(66)92364-6 2. Ларина В. Н., Головко М. Г., Ларин В. Г. Влияние коронавирусной инфекции (covid-19) на сердечно-сосудистую систему. Вестник РГМУ 2, 2020, 5-13. 3. Абатуров А.Е. , Агафонова Е.А., Кривуша Е.Л., Никулина А.А. Патогенез COVID-19. Zdorov’e Rebenka. 2020;15(2):133-144. doi: 10.22141/2224-0551.15.1.2020.200598 4. Мелехина Е.В., Горелов А.В., Музыка А.Д. Клинические особенности течения COVID-19 у детей различных возрастных групп. Обзор литературы к началу апреля 2020 года. Вопросы практической педиатрии. 2020; 15(2): 7–20. (In Russian). DOI: 10.20953/1817-7646-2020- 2-7-20. 5. Luk HKH, Li X, Fung J, Lau SKP, Woo PCY. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infect Genet Evol. 2019 Jul;71:21 -30. DOI: 10.1016/j.meegid.2019.03.001 6. Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533–535. doi: 10.1038/s41423-020-0402-2. 7. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S01406736(20)30628-0 8. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010 Aug;48(8):2940-7. DOI: 10.1128/JCM.00636-10 9. Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, et al. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Infect. 2017 Jan;74(1):29-41. DOI: 10.1016/j.jinf.2016.09.003 10. Ioana M Ciuca. COVID-19 in Children: An Ample Review Risk Manag Healthc Policy. 2020; 13: 661–669. doi: 10.2147/RMHP.S257180 11. Заплатников А.Л., Свинцицкая В.И. COVID-19 и дети. РМЖ. 2020;1(*):1–3. 12. Liu W., Zhang Q., Chen J. et al. Detection of COVID-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020. https://www. nejm.org/doi/10.1056/NEJMc2003717. DOI: 10.1056/NEJMc2003717. 13. Chan J.F., Yuan S., Kok K.H. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. 14. Zhang Y.P. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020;41:145–151. 15. Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020 Mar 2;119 (3):670–673. DOI: 10.1016/j.jfma.2020.02.009. 16. Lu X., Zhang L., Du H. et al. SARS-CoV-2 infection in children. N Engl J Med. 2020 Mar 18; [e-pub]. DOI:.1056/NEJMc2005073 17. Centers for Disease Control and Prevention. Care for Breastfeeding Women. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/care-for-breastfeeding-women. Accessed April 01, 2020 18. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51‐60. doi:10.21037/tp.2020.02.06 19. Fan C, Lei D, Fang C, et al. Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry? Clin Infect Dis. 2020:ciaa226. doi:10.1093/cid/ciaa226. 20. Александрович Ю.С., Байбарина Е.Н., Баранов А.А., и др. Ведение детей с заболеванием, вызванным новой коронавирусной инфекцией (SARS-CoV-2). Педиатрическая фармакология. 2020; 17 (2): 103–118. doi: 10.15690/ pf.v17i2.2096 RE-HEALTH JOURNAL – 1(9) 2021 124 RE-HEALTH JOURNAL 21. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020 Mar 17. DOI: 10.1001/jama.2020.4344 22. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020 Feb 14. DOI: 10.1001/ jama.2020.2131, 23. Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020 Feb 5. DOI: 10.1007/s12519-020-00345-5 24. Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: different points from adults. Ped Pulmonol. 2020;55:1169–1174. doi:10.1002/ppul.24718 25. Schroeder AR, Wilson KM, Ralston SL. COVID-19 and Kawasaki disease: finding the signal in the noise. Hosp Pediatr. 2020;hpeds.2020–000356. doi:10.1542/hpeds.2020-000356 26. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China,”. Pediatrics. 2020;145(6):e20200702. doi:10.1542/peds.2020-0702 27. Fang F, Zhao D, Chen Y. Recommendations for the diagnosis, prevention, and control of the 2019 novel coronavirus infection in children (first interim edition). Zhonghua Er Ke Za Zhi. 2020;145. 28. Shen K, Yang Y, Wang T, et al.; Global Pediatric Pulmonology Alliance. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr. 2020:1 –9. doi:10.1007/s12519-020- 00343-7, 29. Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its im pact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020 30. Global surveillance for COVID-19 caused by human infection with COVID-19 virus Interim guidance; March 20, 2020. Available from: www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019- ncov). Accessed June11, 2020 31. Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020;0.1002/jmv.25770. doi: 10.1002/jmv.25770 32. Li W, Cui H, Li K, et al. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol. 2020;50(6):796–799. doi: 10.1007/s00247-020-04656-7.]. 33. Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020; j/cclm.ahead-of-print/cclm-2020-0272/cclm-2020-0272. xm. doi: 10.1515/cclm-2020-0272. 34. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507– 513. doi: 10.1016/S0140-6736(20)30211-7. 35. Намазова-Баранова Л.С., Баранов А.А. Коронавирусная инфекция у детей (состояние на февраль 2020). Педиатрическая фармакология. 2020; 17 (1): 7–11. doi: 10.15690/pf.v17i1.2076) 36. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–434. doi:10.1016/S1473-3099(20)30086-4 37. Ji LN, Chao S, Wang YJ, et al. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World J Pediatr. 2020:1 –4. doi:10.1007/s12519-020-00356-2. 38. Ng M, Lee E, Yang J, et al. Imaging Profile of the COVID-19 Infection: radiologic findings and literature review. Radiology. 2020;2(1):e200034. doi:10.1148/ryct.2020200034 39. J Clin Virol. Clinical features of pediatric patients with coronavirus disease (COVID-19) 2020 Jun; 127: 104377. doi: 10.1016/j.jcv.2020.104377 40. Намазова-Баранова Л.С. Коронавирусная инфекция (COVID-19) у детей (состояние на апрель 2020). Педиатрическая фармакология. 2020; 17 (2): 85–94. doi: 10.15690/pf.v17i2.2094, 41. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370–1371. doi: 10.1056/NEJMc2003717. 42. Zheng F, Liao C, Fan QH, et al. Clinical characteristics of children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–280. doi: 10.1007/s11596-020-2172-6. 43. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;S01909622(20)30657-5. doi: 10.1016/j.jaad.2020.04.044. 44. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: a diagnostic clue? Pediatr Dermatol. 2020. doi: 10.1111/pde.14201 RE-HEALTH JOURNAL – 1(9) 2021 125 RE-HEALTH JOURNAL 45. Bouadma L, Lescure F, Lucet J, Yazdanpanah Y, Timsit JF. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46(4):579–582. doi:10.1007/s00134-020-05967-x 46. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. doi:10.1186/s40779-020-0233-6 47. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi:10.1136/bmj.m606, 48. Sun D, Li H, Lu X, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr. 2020. doi:10.1007/s12519-020-00354-4 |